Effect of hepatocyte growth factor on gene expression of extracellular matrix during wound healing of the injured rat vocal fold

Annals of Otology, Rhinology and Laryngology

Volumn 117, Issue 9, 2008, Pages 696-702

  Ohno, Tsunehisa ^a   French, Lesley C ^a   Hirano, Shigeru ^b   Ossoff, Robert H ^a   Rousseau, Bernard ^a,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Extracellular matrix; Hepatocyte growth factor; Hyaluronan synthase; Procollagen; Transforming growth factor 1; Vocal fold wound healing

Indexed keywords

HYALURONAN SYNTHASE 1; HYALURONAN SYNTHASE 2; HYALURONAN SYNTHASE 3; MESSENGER RNA; PROCOLLAGEN; SCATTER FACTOR; SYNTHETASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; POST HOC ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VOCAL CORD DISORDER; VOCAL CORD TRAUMA; WOUND HEALING;

EID: 54249095506     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940811700912     Document Type: Article

References (30)

1. Ford CN, Bless DM. Selected problems treated by vocal fold injection of collagen. Am J Otolaryngol 1993;14:257-61.
2. Ford CN, Bless DM. Collagen injection in the scarred vocal fold. J Voice 1987;1:116-8.
3. Staskowski PA, Ford CN, Inagi K. The histologic fate of autologous collagen injected into the canine vocal fold. Otolaryngol Head Neck Surg 1998;118:187-90.
4. Kriesel KJ, Thibeault SL, Chan RW, et al. Treatment of vocal fold scarring: rheological and histological measures of homologous collagen matrix. Ann Otol Rhinol Laryngol 2002;111:884-9.
5. Brandenburg JH, Kirkham W, Koschkee D. Vocal cord augmentation with autogenous fat. Laryngoscope 1992;102:495-500.
6. Matsumoto K, Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 1997;239:639-44.
7. Hirano S, Bless DM, Rousseau B, et al. Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model. Laryngoscope 2004;114:548-56.
8. Hirano S, Bless DM, Nagai H, et al. Growth factor therapy for vocal fold scarring in a canine model. Ann Otol Rhinol Laryngol 2004;113:777-85.
9. Ohno T, Hirano S, Kanemaru S, et al. Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model. Ann Otol Rhinol Laryngol 2007;116:762-9.
10. Tateya T, Tateya I, Sohn JH, Bless DM. Histologic characterization of rat vocal fold scarring. Ann Otol Rhinol Laryngol 2005;114:183-91.
11. Lim X, Tateya I, Tateya T, Munoz-Del-Rio A, Bless DM. Immediate inflammatory response and scar formation in wounded vocal folds. Ann Otol Rhinol Laryngol 2006;115:921-9.
12. Song W, Ergul A. Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: relation to vessel size. Cardiovasc Diabetol 2006;17:3.
13. Tashiro T, Hiraoka H, Ikeda Y, et al. Effect of GDF-5 on ligament healing. J Orthop Res 2006;24:71-9.
14. Oishi Y, Kato H, Noguchi T. Dietary protein as a potent regulator of the hyaluronan synthase gene in rat skin. Biosci Biotechnol Biochem 2003;67:736-42.
15. Fujisaki K, Tanabe N, Suzuki N, et al. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells. Life Sci 2006;78:1975-82.
16. Colwell AS, Longaker MT, Lorenz HP. Fetal wound healing. Front Biosci 2003;8:s1240-s1248.
17. Ferguson MW, O'Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 2004;359:839-50.
18. Verrecchia F, Mauviel A. Control of connective tissue gene expression by TGF beta: role of Smad proteins in fibrosis. Curr Rheumatol Rep 2002;4:143-9.
19. Roberts AB, Sporn MB. Transforming growth factor-β. In: Clark RAF, ed. The molecular and cellular biology of wound repair. Vol 23. New York, NY: Plenum Press, 1996:275-308.
20. Shah M, Foreman DM, Ferguson MW. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 1994;107:1137-57.
21. Liu Y. Hepatocyte growth factor and the kidney. Curr Opin Nephrol Hypertens 2002;11:23-30.
22. Matsumoto K, Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int 2001;59:2023-38.
23. Liu Y, Rajur K, Tolbert E, Dworkin LD. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int 2000;58:2028-43.
24. Mizuno S, Nakamura T. Suppressions of chronic glomerular injuries and TGF-β1 production by HGF in attenuation of murine diabetic nephropathy. Am J Physiol Renal Physiol 2004;286:F134-F143.
25. Thibeault SL, Gray SD, Bless DM, Chan RW, Ford CN. Histologic and rheologic characterization of vocal fold scarring. J Voice 2002;16:96-104.
26. Rousseau B, Hirano S, Scheidt TD, et al. Characterization of vocal fold scarring in a canine model. Laryngoscope 2003;113:620-7.
27. Thibeault SL, Rousseau B, Welham NV, Hirano S, Bless DM. Hyaluronan levels in acute vocal fold scar. Laryngoscope 2004;114:760-4.
28. Rousseau B, Sohn J, Montequin DW, Tateya I, Bless DM. Functional outcomes of reduced hyaluronan in acute vocal fold scar. Ann Otol Rhinol Laryngol 2004;113:767-76.
29. Weigel PH, Fuller GM, LeBoeuf RD. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol 1986;119:219-34.
30. Hirano S, Bless D, Heisey D, Ford C. Roles of hepatocyte growth factor and transforming growth factor beta1 in production of extracellular matrix by canine vocal fold fibroblasts. Laryngoscope 2003;113:144-8.